Regular Article
A Colorimetric Assay for Measuring Activation of Gs- and Gq-Coupled Signaling Pathways

https://doi.org/10.1006/abio.1995.1235Get rights and content

Abstract

Current assays for functional activation of Gs-coupled receptors usually involve quantitation of adenylyl cyclase or measurement of cAMP concentration by radioimmunoassay. The activation of Gq-coupled receptors is commonly assayed by measurement of the production of inositol triphosphate or diacylglycerol from phosphatidylinositol 4,5-bisphosphate or of changes in intracellular calcium. These assays generally require large numbers of cells (105-106) and/or the use of radioactive materials. We have developed a rapid nonradioactive colorimetric assay that utilizes a β-galactosidase (lacZ) gene fused to five copies of the cyclic AMP response element (CRE) to detect the activation of CRE-binding protein that results from an increase in intracellular cAMP or calcium. This assay can be performed using as few as 30,000 cells in a 96-well format with the end products measured simultaneously in a microplate reader. Consequently, a single individual can readily assay 1000 samples a day. Using this assay, the fold increase in β-galactosidase activity was similar in magnitude to increases in cAMP or adenylyl cyclase activity and was approximately linear from 0.01 to 0.27 fmol/cell of intracellular cAMP. Furthermore, pharmacological characterization of one of the melanocortin receptors, mMC5-R, using this assay resulted in a similar order of potency for several melanocortin peptides to that obtained with a commonly used adenylyl cyclase enzyme assay. This assay is also useful for the characterization of Gq-coupled receptors as is demonstrated here using cells transfected with the mouse bombesin receptor. The large-scale capacity of this assay makes it an excellent method for screening molecules of interest acting on Gs- and Gq-coupled receptors.

References (0)

Cited by (185)

  • Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016

    2017, Biochimica et Biophysica Acta - Molecular Basis of Disease
    Citation Excerpt :

    The first reports of altered pigmentation dates back to 1916 [22,23]. Significant advances were achieved with the identification, sequencing, and cloning of the MCRs from 1992 to 1994 [1,2,6,7,9,12,13], coupled with the development of 96-well plate cAMP assays [24]. The genetic information combined with assay platforms generated an experimental paradigm that allowed for the design, synthesis, and investigation of potent, selective compounds for the different receptor subtypes.

View all citing articles on Scopus
View full text